Nintabid 150 Softgel Capsule belongs to the category of 'anti-fibrotic medicine', and it is primarily used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is an irreversible disease marked by a progressive decline in lung function. The tissues in the lungs become swollen and scarred over time, which makes it difficult to breathe deeply. The scarring makes it hard for the lungs to work properly.

Nintabid 150 Softgel Capsule contains 'Nintedanib', which helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Nintabid 150 Softgel Capsule helps in slowing down the progress of idiopathic pulmonary fibrosis.

Always use this medicine as your doctor has told you or per the package leaflet. You must keep to your doctor's instructions to get the maximum benefit. In some cases, you may experience common side effects such as nausea, tiredness, diarrhoea, indigestion, loss of appetite, headache, and photosensitivity. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Consult your doctor before taking Nintabid 150 Softgel Capsule if you are pregnant or breastfeeding. Nintabid 150 Softgel Capsule may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Nintabid 150 Softgel Capsule as it could lead to increased dizziness. Nintabid 150 Softgel Capsule is not recommended for children below 18 years as safety and effectiveness have not been established. Nintabid 150 Softgel Capsule is listed as pregnancy category D. Because Nintabid 150 Softgel Capsule can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Nintabid 150 Softgel Capsule . Consult your doctor if you are breastfeeding; your doctor will decide whether the Nintabid 150 Softgel Capsule can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Nintabid 150 Softgel Capsule is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults. Nintabid 150 Softgel Capsule can help effectively slow the rate of lung function decline by 50%. Nintabid 150 Softgel Capsule helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Nintabid 150 Softgel Capsule helps in slowing down the progress of idiopathic pulmonary fibrosis.

Do not use Nintabid 150 Softgel Capsule if you are allergic to any components present in Nintabid 150 Softgel Capsule . Nintabid 150 Softgel Capsule is listed as pregnancy category D; because Nintabid 150 Softgel Capsule can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Nintabid 150 Softgel Capsule . Consult your doctor if you are breastfeeding; your doctor will decide whether the Nintabid 150 Softgel Capsule can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects. Nintabid 150 Softgel Capsule may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Nintabid 150 Softgel Capsule as it could lead to increased dizziness. Nintabid 150 Softgel Capsule is not recommended for children below 18 years as safety and effectiveness have not been established.